Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature

J Pediatr Hematol Oncol. 2024 May 1;46(4):211-215. doi: 10.1097/MPH.0000000000002853. Epub 2024 Apr 4.

Abstract

Diffuse intrinsic pontine gliomas are lethal tumors with a prognosis generally less than 1 year. Few cases of survivors of 5 years or more have been reported. This case report highlights the journey of a 9.5-year survivor who underwent 3 rounds of focal radiotherapy; she experienced 6 years of progression-free survival following the first round but ultimately succumbed to her disease. An autopsy revealed a favorable IDH1 mutation and the absence of H3K27M. This case reiterates the importance of extensive molecular analyses in diffuse intrinsic pontine gliomas and explores the potential benefit of re-irradiation in patients with positive responses and long periods of remission.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Brain Stem Neoplasms* / mortality
  • Brain Stem Neoplasms* / pathology
  • Brain Stem Neoplasms* / therapy
  • Cancer Survivors
  • Child
  • Diffuse Intrinsic Pontine Glioma* / genetics
  • Diffuse Intrinsic Pontine Glioma* / pathology
  • Diffuse Intrinsic Pontine Glioma* / therapy
  • Fatal Outcome
  • Female
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Mutation
  • Prognosis
  • Survivorship

Substances

  • Isocitrate Dehydrogenase
  • IDH1 protein, human